Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:1422-1426
doi: 10.1161/hy1201.097196
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Susic, D.
Right arrow Articles by Frohlich, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Susic, D.
Right arrow Articles by Frohlich, E. D.
Related Collections
Right arrow Remodeling
Right arrow Cardiovascular Pharmacology
Right arrow Hypertrophy
Right arrow Chronic ischemic heart disease

(Hypertension. 2001;38:1422.)
© 2001 American Heart Association, Inc.


Fourth Workshop on Structure and Function of Large Arteries: Part III

Isolated Systolic Hypertension in Elderly WKY Is Reversed With L-Arginine and ACE Inhibition

Dinko Susic; Jasmina Varagic; Edward D. Frohlich

From the Alton Ochsner Medical Foundation, New Orleans, La.

Correspondence to Edward D. Frohlich, MD, Alton Ochsner Distinguished Scientist, Alton Ochsner Medical Foundation, 1516 Jefferson Hwy, New Orleans, LA 70121. E-mail efrohlich{at}ochsner.org

Abstract

This study was designed to examine the preventability of progressive deterioration of cardiovascular structure and function in very old Wistar-Kyoto (WKY) rats with isolated systolic hypertension (ISH). To this end, male 18-month-old normotensive WKY rats were given either placebo or L-arginine (70 mg · kg-1 · d-1) and an ACE inhibitor (enalapril, 30 mg · kg-1 · d-1) for 6 months. These control and treated rats were studied at the age of 2 years by examining: cardiovascular mass and collagen content, cardiac function, and systemic and regional (including coronary) hemodynamics. Additional data obtained in adult, 35-week-old WKY are included for comparison. ISH associated with increased total peripheral resistance was found in the old, untreated WKY, and this was prevented by the combined treatment. The untreated rats also exhibited impaired left ventricular function, as denoted by increased left ventricular end-diastolic pressure and reduced maximal rates of rise and fall of left ventricular pressure. These functional changes were also ameliorated with the combined treatment. Coronary hemodynamics were also compromised in the untreated WKY; and therapy improved coronary flow reserve and minimal coronary vascular resistance in both ventricles of the old WKY in parallel with reduction of arterial pressure. Blood flow to various other organs was uncompromised in the old rats, although increased vascular resistances were observed in untreated old WKY with ISH. These changes were also improved by the combined therapy. Finally, therapy diminished left ventricular mass and collagen concentration in old WKY compared with the untreated WKY. However, when compared with the 35-week-old WKY, both groups of old WKY (untreated and treated) demonstrated myocardial fibrosis, depressed ventricular function, and compromised coronary hemodynamics. Therefore, L-arginine and ACE inhibitory therapy ameliorated the hypertensive and associated adverse cardiovascular changes in old WKY, although it failed to improve totally the progressive deterioration of cardiovascular structure and function that occurred with aging. The results suggest that different mechanisms may be responsible for the hypertension- and age-related cardiovascular changes, although they may appear to be similar.


Key Words: isolated systolic hypertension • endothelial function • ventricular function • coronary hemodynamics • myocardial collagen concentration • angiotensin-converting enzyme inhibitors • L-arginine




This article has been cited by other articles:


Home page
HypertensionHome page
S. Racasan, B. Braam, D. M. van der Giezen, R. Goldschmeding, P. Boer, H. A. Koomans, and J. A. Joles
Perinatal L-Arginine and Antioxidant Supplements Reduce Adult Blood Pressure in Spontaneously Hypertensive Rats
Hypertension, July 1, 2004; 44(1): 83 - 88.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. H. Cingolani, X.-P. Yang, Y.-H. Liu, M. Villanueva, N.-E. Rhaleb, and O. A. Carretero
Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats
Hypertension, May 1, 2004; 43(5): 1067 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Safar and P. Laurent
Pulse pressure and arterial stiffness in rats: comparison with humans
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1363 - H1369.
[Full Text] [PDF]


Home page
HypertensionHome page
E. D. Frohlich
Local Hemodynamic Changes in Hypertension: Insights for Therapeutic Preservation of Target Organs
Hypertension, December 1, 2001; 38(6): 1388 - 1394.
[Abstract] [Full Text] [PDF]